CV Sciences, Inc.
CVSI· OTC
Released May 14, 2024, before the open
10-Q filed May 15, 2024, 45 days after period end · 0000950170-24-059926
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $4.00M | $4.15M | $4.45M | $4.84M |
| Net Income | -$628.00K | $5.71M | -$2.22M | -$3.13M |
| EPS Diluted |
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
| $0.00 |
| $0.04 |
| -$0.02 |
| -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.